BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5319621)

  • 21. [Cyto-diagnostic test results following sputum provocation with Bisolvon].
    Fischnaller M; Schwarzenberg E; Wrbka E
    Wien Klin Wochenschr; 1967 Jan; 79(1):1-3. PubMed ID: 5340279
    [No Abstract]   [Full Text] [Related]  

  • 22. [A derivative of benzyl-amine in the therapy of respiratory diseases in children].
    Gambi R; Ongaro F; Paoli R; Russo U
    Minerva Med; 1969 Sep; 60(76):3575-9. PubMed ID: 5823753
    [No Abstract]   [Full Text] [Related]  

  • 23. [Practical trials with Bisolvon, a new bronchial expectorant].
    Kleine-Allekotte B
    Hippokrates; 1965 Jul; 36(13):521-3. PubMed ID: 5319471
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of a clinical trial of the use of a methoxyamine (cefuroxime) in respiratory tract infections in children].
    Castello D; Sacchetti L; Brero P; Poncini L
    Minerva Pediatr; 1981 Sep; 33(17):881-6. PubMed ID: 7031458
    [No Abstract]   [Full Text] [Related]  

  • 25. [Favorable effect of passive inhalation (insufflation) of intal in obstructive bronchitis in children in the first few years of life].
    Zychowicz C; Chorazykiewicz M
    Pediatr Pol; 1987 Jun; 62(6):404-9. PubMed ID: 3313229
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term treatment of the bronchitis syndrome with combinations of a secretolytic agent (Bisolvon-Linctus, Bisulvonamide, Bisolvonmycin)].
    Görlach FW
    Hippokrates; 1969 Nov; 40(21):850-3. PubMed ID: 5382635
    [No Abstract]   [Full Text] [Related]  

  • 27. [Expectorants. Help for acute cold bronchitis?].
    Polk B
    Med Monatsschr Pharm; 2002 Nov; 25(11):379-81. PubMed ID: 12474345
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical evaluation of the therapeutic efficacy of a new antiphlogistic and mucus-regulating drug, guaimesal, in acute and chronic bronchopneumopathies].
    Bandera M; Fioretti M
    Clin Ter; 1984 Sep; 110(5):455-61. PubMed ID: 6238760
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment with Bricanyl elixir in obstructive bronchitis and asthma of childhood.
    Vadász A; Osváth P; Fornai K
    Ther Hung; 1983; 31(3):137-8. PubMed ID: 6400473
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of obstructive infant bronchitis].
    Reinhardt D
    Monatsschr Kinderheilkd; 1984 Jun; 132(6):448-53. PubMed ID: 6147749
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experience with a new mucus disolving agent (Bisolvon) for the therapy of whooping cough and diseases of the respiratory tract].
    Ertogan F
    Kinderarztl Prax; 1967 Apr; 35(4):141-6. PubMed ID: 5594869
    [No Abstract]   [Full Text] [Related]  

  • 32. [ Pediatric patients with bronchiolitis or obstructive bronchitis].
    Korppi M; Reijonen T; Remes K
    Duodecim; 1996; 112(24):2375-82. PubMed ID: 10605238
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Ercillo L; Mollica G
    Minerva Med; 1969 Sep; 60(76):3604-6. PubMed ID: 5823758
    [No Abstract]   [Full Text] [Related]  

  • 34. Expectorant properties of bromhexine.
    Palmer KN; Hamilton WF
    Lancet; 1970 Mar; 1(7646):563. PubMed ID: 4190369
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the treatment of spastic bronchitis in infants and children using a new bronchospasmolytic agent].
    Ertogan F; Stolting G; Russ D
    Dtsch Med J; 1969 Jun; 20(12):413-5. PubMed ID: 5801770
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acetylcysteine in bronchitis and pneumonia].
    Vogelmeier C
    Internist (Berl); 1999 Oct; 40(10):1102-3. PubMed ID: 10610368
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long term treatment with biosolvonamid].
    Höhfeld HH
    Med Monatsschr; 1968 Sep; 22(9):411-4. PubMed ID: 5702822
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of mucolytic and expectorant drugs on tracheobronchial clearance in chronic bronchitis.
    Clarke SW; Thomson ML; Pavia D
    Eur J Respir Dis Suppl; 1980; 110():179-91. PubMed ID: 6938381
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of therapeutic effect of 2 application forms of a combination of N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium-chloride and sulfanilamidopyrimidine. A widespread mutual test].
    Oligschläger G
    Arzneimittelforschung; 1969 Oct; 19(10):1710-7. PubMed ID: 5395373
    [No Abstract]   [Full Text] [Related]  

  • 40. [Multicenter, controlled, double-blind study of the efficacy and tolerance of Vectrine (erdostein) versus placebo in the treatment of stabilized chronic bronchitis with hypersecretion].
    Aubier M; Berdah L
    Rev Mal Respir; 1999 Sep; 16(4):521-8. PubMed ID: 10549062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.